Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  capecitabine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 548 for your search:
Start Over
A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML18527, NCT00121836
XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML18530, NCT00127933
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EGF103659, NCT00338247
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML20592, NCT00502671
Study of Biomarkers in Patients Undergoing Chemotherapy for Metastatic Colorectal Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000574159, CHUL-BIO-COLON, INCA-RECF0356, RECF0356, NCT00559676
OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML21380, NCT00577031
Combination Chemotherapy in Treating Older Patients With Solid Tumour,
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 75 and over
Sponsor: Other
Protocol IDs: CDR0000593133, GERCOR-OLD, EudraCT-2007004103-36, GERCOR-OLD07-SA07-1, NCT00664911
Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (= 75 Years)
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 75 and over
Sponsor: Other
Protocol IDs: I07028, N° EudraCT : 2008-001195-7, NCT00812864
Pharmacokinetic Study of Adjuvant Capecitabine After Resection of Pancreatic Adenocarcinoma
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CAP001, PDDG/CAP001, NCT00854477
A Translational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ASCENT)
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML25753, NCT01588990
Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NBCG10, REK 378-04-03133, NMA 03-07568, NCT00201435
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: AG0501CR, NCT00294359
Standard Versus Continuous Capecitabine in Advanced Breast Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 05/237, NCT00418028
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
Phase: Phase III, Phase II
Type: Health services research, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000558804, WCTU-SCOPE-1, EU-20739, EUDRACT-2006-002241-37, ISRCTN47718479, CTA-17853/0202/001-0001, NCT00509561
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to79
Sponsor: Other
Protocol IDs: 2007-07-RCT-LCI1, NCT00561522
Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000641309, PACT-7, SRSI-PACT-7, EU-20932, NCT00960284
Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: Other
Protocol IDs: GBG 52, 2008-003995-23, NCT01204437
Phase III Randomized Study of Bevacizumab With Capecitabine Versus Capecitabine Alone in Women With Previously Treated Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: GENENTECH-AVF2119g, GUMC-00299, MSKCC-01008, UAB-0028, UAB-F001009003, NCT00012285
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 65 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068891, U10CA031946, CALGB-49907, ECOG-CALGB-49907, CAN-NCIC-MAC1, SWOG-CALGB-49907, MAC1, NCT00024102
Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: SAKK 44/00, SWS-SAKK-44/00, CECOG/PAN-1.3.001, EU-20142, NCT00030732
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NSABP R-04, CALGB-NSABP-R-04, NCT00058474
Start Over